-
1
-
-
0033514987
-
From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future
-
Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999, 99:1091-1100.
-
(1999)
Circulation
, vol.99
, pp. 1091-1100
-
-
Kawai, C.1
-
2
-
-
0036211870
-
Pathophysiology of viral myocarditis: the role of humoral immune response
-
Maisch B., Ristić A.D., Hufnagel G., Pankuweit S. Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc Pathol 2002, 11:112-122.
-
(2002)
Cardiovasc Pathol
, vol.11
, pp. 112-122
-
-
Maisch, B.1
Ristić, A.D.2
Hufnagel, G.3
Pankuweit, S.4
-
3
-
-
21644483408
-
A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection
-
Dan M., Chantler J.K. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection. J Virol 2005, 79:9285-9295.
-
(2005)
J Virol
, vol.79
, pp. 9285-9295
-
-
Dan, M.1
Chantler, J.K.2
-
4
-
-
0027336111
-
High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis
-
Fohlman J., Pauksen K., Morein B., Bjare U., Ilbäck N.G., Friman G. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand J Infect Dis Suppl 1993, 88:103-108.
-
(1993)
Scand J Infect Dis Suppl
, vol.88
, pp. 103-108
-
-
Fohlman, J.1
Pauksen, K.2
Morein, B.3
Bjare, U.4
Ilbäck, N.G.5
Friman, G.6
-
5
-
-
0031714796
-
Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization
-
Henke A., Wagner E., Whitton J.L., Zell R., Stelzner A. Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization. J Virol 1998, 72:8327-8331.
-
(1998)
J Virol
, vol.72
, pp. 8327-8331
-
-
Henke, A.1
Wagner, E.2
Whitton, J.L.3
Zell, R.4
Stelzner, A.5
-
6
-
-
0035122776
-
DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice
-
Henke A., Zell R., Stelzner A. DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice. Antiviral Res 2001, 49:49-54.
-
(2001)
Antiviral Res
, vol.49
, pp. 49-54
-
-
Henke, A.1
Zell, R.2
Stelzner, A.3
-
7
-
-
13444278886
-
Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge
-
Kim J.-Y., Jeon E.-S., Lim B.-K., Kim S.-M., Chung S.-K., Kim J.-M., et al. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Vaccine 2005, 23:1672-1679.
-
(2005)
Vaccine
, vol.23
, pp. 1672-1679
-
-
Kim, J.-Y.1
Jeon, E.-S.2
Lim, B.-K.3
Kim, S.-M.4
Chung, S.-K.5
Kim, J.-M.6
-
8
-
-
0000309474
-
Proteolytic processing in the replication of picornaviruses
-
Harris K.S., Hellen C.U.T., Wimmer E. Proteolytic processing in the replication of picornaviruses. Semin Virol 1990, 1:323-333.
-
(1990)
Semin Virol
, vol.1
, pp. 323-333
-
-
Harris, K.S.1
Hellen, C.U.T.2
Wimmer, E.3
-
9
-
-
0025011840
-
Proteolytic processing of picornaviral polyprotein
-
Palmenberg A.C. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol 1990, 44:603-623.
-
(1990)
Annu Rev Microbiol
, vol.44
, pp. 603-623
-
-
Palmenberg, A.C.1
-
10
-
-
0000327130
-
Picornaviridae: the viruses and their replication
-
Rueckert R.R. Picornaviridae: the viruses and their replication. Fields virology 1996, pp. 609-54. third ed.
-
(1996)
Fields virology
, pp. 609-54
-
-
Rueckert, R.R.1
-
11
-
-
0028179348
-
Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides
-
Haarmann C.M., Schwimmbeck P.L., Mertens T., Schultheiss H.P., Strauer B.E. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology 1994, 200:381-389.
-
(1994)
Virology
, vol.200
, pp. 381-389
-
-
Haarmann, C.M.1
Schwimmbeck, P.L.2
Mertens, T.3
Schultheiss, H.P.4
Strauer, B.E.5
-
12
-
-
0035667319
-
The group B coxsackieviruses and myocarditis
-
Kim K.S., Hufnagel G., Chapman N.M., Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol 2001, 11:355-368.
-
(2001)
Rev Med Virol
, vol.11
, pp. 355-368
-
-
Kim, K.S.1
Hufnagel, G.2
Chapman, N.M.3
Tracy, S.4
-
13
-
-
0025249934
-
Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects
-
Beck M.A., Chapman N.M., McManus B.M., Mullican J.C., Tracy S. Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. Am J Pathol 1990, 136:669-681.
-
(1990)
Am J Pathol
, vol.136
, pp. 669-681
-
-
Beck, M.A.1
Chapman, N.M.2
McManus, B.M.3
Mullican, J.C.4
Tracy, S.5
-
14
-
-
0034003423
-
A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice
-
Chapman N.M., Ragland A., Leser J.S., Höfling K., Willian S., Semler B.L., et al. A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice. J Virol 2000, 74:4047-4056.
-
(2000)
J Virol
, vol.74
, pp. 4047-4056
-
-
Chapman, N.M.1
Ragland, A.2
Leser, J.S.3
Höfling, K.4
Willian, S.5
Semler, B.L.6
-
15
-
-
0025105736
-
Vaccination of Balb/c mice against enteroviral mediated myocarditis
-
Fohlman J., Ilbäck N.G., Friman G., Morein B. Vaccination of Balb/c mice against enteroviral mediated myocarditis. Vaccine 1990, 8:381-384.
-
(1990)
Vaccine
, vol.8
, pp. 381-384
-
-
Fohlman, J.1
Ilbäck, N.G.2
Friman, G.3
Morein, B.4
-
16
-
-
0028561964
-
Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses
-
See D.M., Tilles J.G. Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses. Scand J Infect Dis 1994, 26:739-747.
-
(1994)
Scand J Infect Dis
, vol.26
, pp. 739-747
-
-
See, D.M.1
Tilles, J.G.2
-
17
-
-
0030984921
-
Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain
-
Zhang H., Morgan-Capner P., Latif N., Pandolfino Y.A., Fan W., Dunn M.J., et al. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain. Am J Pathol 1997, 150:2197-2207.
-
(1997)
Am J Pathol
, vol.150
, pp. 2197-2207
-
-
Zhang, H.1
Morgan-Capner, P.2
Latif, N.3
Pandolfino, Y.A.4
Fan, W.5
Dunn, M.J.6
-
18
-
-
4143071461
-
Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection
-
Xu W., Shen Y., Jiang Z., Wang Y., Chu Y., Xiong S. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection. Vaccine 2004, 22:3603-3612.
-
(2004)
Vaccine
, vol.22
, pp. 3603-3612
-
-
Xu, W.1
Shen, Y.2
Jiang, Z.3
Wang, Y.4
Chu, Y.5
Xiong, S.6
-
19
-
-
84907713436
-
Immunization in pregnancy
-
Gruslin A., Steben M., Halperin S., Money D.M., Yudin M.H. Immunization in pregnancy. J Obstet Gynaecol Can 2009, 31:1085-1101.
-
(2009)
J Obstet Gynaecol Can
, vol.31
, pp. 1085-1101
-
-
Gruslin, A.1
Steben, M.2
Halperin, S.3
Money, D.M.4
Yudin, M.H.5
-
20
-
-
0035852349
-
Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus
-
Wu C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001, 20:895-904.
-
(2001)
Vaccine
, vol.20
, pp. 895-904
-
-
Wu, C.N.1
Lin, Y.C.2
Fann, C.3
Liao, N.S.4
Shih, S.R.5
Ho, M.S.6
-
21
-
-
0042825878
-
Virus-like particles as immunogens
-
Noad R., Roy P. Virus-like particles as immunogens. Trends Microbiol 2003, 11:438-444.
-
(2003)
Trends Microbiol
, vol.11
, pp. 438-444
-
-
Noad, R.1
Roy, P.2
-
22
-
-
33748794562
-
Virus-like particles: passport to immune recognition
-
Grgacic E.V.L., Anderson D.A. Virus-like particles: passport to immune recognition. Methods 2006, 40:60-65.
-
(2006)
Methods
, vol.40
, pp. 60-65
-
-
Grgacic, E.V.L.1
Anderson, D.A.2
-
23
-
-
33645050114
-
Expression, purification and characterization of enterovirus-71 virus-like particles
-
Chung Y.-C., Huang J.-H., Lai C.-W., Sheng H.-C., Shih S.-R., Ho M.-S., et al. Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 2006, 12:921-927.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 921-927
-
-
Chung, Y.-C.1
Huang, J.-H.2
Lai, C.-W.3
Sheng, H.-C.4
Shih, S.-R.5
Ho, M.-S.6
-
24
-
-
0030764123
-
Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae
-
Rombaut B., Jore J.P. Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae. J Gen Virol 1997, 78(Pt 8):1829-1832.
-
(1997)
J Gen Virol
, vol.78
, Issue.PART 8
, pp. 1829-1832
-
-
Rombaut, B.1
Jore, J.P.2
-
25
-
-
40849137446
-
Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge
-
Chung Y.-C., Ho M.-S., Wu J.-C., Chen W.-J., Huang J.-H., Chou S.-T., et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
-
(2008)
Vaccine
, vol.26
, pp. 1855-1862
-
-
Chung, Y.-C.1
Ho, M.-S.2
Wu, J.-C.3
Chen, W.-J.4
Huang, J.-H.5
Chou, S.-T.6
-
26
-
-
77952314452
-
Introduction. The human papillomavirus VLP vaccines
-
Stanley M. Introduction. The human papillomavirus VLP vaccines. Gynecol Oncol 2010, 118:S1.
-
(2010)
Gynecol Oncol
, vol.118
-
-
Stanley, M.1
-
27
-
-
77957936654
-
Virus-like particles in vaccine development
-
Roldão A., Mellado M.C.M., Castilho L.R., Carrondo M.J.T., Alves P.M. Virus-like particles in vaccine development. Expert Rev Vaccines 2010, 9:1149-1176.
-
(2010)
Expert Rev Vaccines
, vol.9
, pp. 1149-1176
-
-
Roldão, A.1
Mellado, M.C.M.2
Castilho, L.R.3
Carrondo, M.J.T.4
Alves, P.M.5
-
28
-
-
79953104927
-
Prevention of cancer by prophylactic human papillomavirus vaccines
-
Kwak K., Yemelyanova A., Roden R.B.S. Prevention of cancer by prophylactic human papillomavirus vaccines. Curr Opin Immunol 2011, 23:244-251.
-
(2011)
Curr Opin Immunol
, vol.23
, pp. 244-251
-
-
Kwak, K.1
Yemelyanova, A.2
Roden, R.B.S.3
-
29
-
-
0027368217
-
Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5'-nontranslated region does not contain major attenuation determinants
-
Zhang H.Y., Yousef G.E., Cunningham L., Blake N.W., OuYang X., Bayston T.A., et al. Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5'-nontranslated region does not contain major attenuation determinants. J Med Virol 1993, 41:129-137.
-
(1993)
J Med Virol
, vol.41
, pp. 129-137
-
-
Zhang, H.Y.1
Yousef, G.E.2
Cunningham, L.3
Blake, N.W.4
OuYang, X.5
Bayston, T.A.6
-
30
-
-
0027185673
-
Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein
-
Bräutigam S., Snezhkov E., Bishop D.H. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein. Virology 1993, 192:512-524.
-
(1993)
Virology
, vol.192
, pp. 512-524
-
-
Bräutigam, S.1
Snezhkov, E.2
Bishop, D.H.3
-
32
-
-
0019806848
-
Comparison of capsid polypeptides of group B coxsackie-viruses and polypeptide synthesis in infected cells
-
Chatterjee N.K., Tuchowski C. Comparison of capsid polypeptides of group B coxsackie-viruses and polypeptide synthesis in infected cells. Arch Virol 1981, 70:255-269.
-
(1981)
Arch Virol
, vol.70
, pp. 255-269
-
-
Chatterjee, N.K.1
Tuchowski, C.2
-
33
-
-
0020662357
-
Preliminary characterization of coxsackievirus B3 temperature-sensitive mutants
-
Gauntt C.J., Trousdale M.D., Lee J.C., Paque R.E. Preliminary characterization of coxsackievirus B3 temperature-sensitive mutants. J Virol 1983, 45:1037-1047.
-
(1983)
J Virol
, vol.45
, pp. 1037-1047
-
-
Gauntt, C.J.1
Trousdale, M.D.2
Lee, J.C.3
Paque, R.E.4
-
34
-
-
84862818968
-
-
Baculovirus_vector_system_manual.
-
Baculovirus_vector_system_manual. http://www.bdbiosciences.com/documents/Baculovirus_vector_system_manual.pdf.
-
-
-
-
35
-
-
69849107576
-
Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli
-
Lee C.-D., Yan Y.-P., Liang S.-M., Wang T.-F. Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli. J Biomed Sci 2009, 16:69.
-
(2009)
J Biomed Sci
, vol.16
, pp. 69
-
-
Lee, C.-D.1
Yan, Y.-P.2
Liang, S.-M.3
Wang, T.-F.4
-
36
-
-
1842298735
-
Expression and self-assembly of empty virus-like particles of hepatitis E virus
-
Li T.C., Yamakawa Y., Suzuki K., Tatsumi M., Razak M.A., Uchida T., et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997, 71:7207-7213.
-
(1997)
J Virol
, vol.71
, pp. 7207-7213
-
-
Li, T.C.1
Yamakawa, Y.2
Suzuki, K.3
Tatsumi, M.4
Razak, M.A.5
Uchida, T.6
-
37
-
-
57149121466
-
Expression of the Hepatitis A virus empty capsids in suspension cells and transgenic tobacco plants (Nicotiana tabacum L.)
-
Lopez A., Roasbal Y., Hernandez A., Gonzalez B., Rios J., Perez M., et al. Expression of the Hepatitis A virus empty capsids in suspension cells and transgenic tobacco plants (Nicotiana tabacum L.). Biotechnologia Aplicada 2008, 25:42-46.
-
(2008)
Biotechnologia Aplicada
, vol.25
, pp. 42-46
-
-
Lopez, A.1
Roasbal, Y.2
Hernandez, A.3
Gonzalez, B.4
Rios, J.5
Perez, M.6
-
38
-
-
33947609904
-
Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus
-
Zhang Y.-L., Guo Y.-J., Wang K.-Y., Lu K., Li K., Zhu Y., et al. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Scand J Immunol 2007, 65:320-328.
-
(2007)
Scand J Immunol
, vol.65
, pp. 320-328
-
-
Zhang, Y.-L.1
Guo, Y.-J.2
Wang, K.-Y.3
Lu, K.4
Li, K.5
Zhu, Y.6
-
39
-
-
0035858098
-
Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice
-
Li T.-C., Takeda N., Miyamura T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 2001, 19:3476-3484.
-
(2001)
Vaccine
, vol.19
, pp. 3476-3484
-
-
Li, T.-C.1
Takeda, N.2
Miyamura, T.3
-
40
-
-
0344234364
-
Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles
-
Li T.-C., Suzaki Y., Ami Y., Dhole T.N., Miyamura T., Takeda N. Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine 2004, 22:370-377.
-
(2004)
Vaccine
, vol.22
, pp. 370-377
-
-
Li, T.-C.1
Suzaki, Y.2
Ami, Y.3
Dhole, T.N.4
Miyamura, T.5
Takeda, N.6
-
41
-
-
60149087397
-
The expression, purification, and immunogenicity of a new chimeric virus-like particle
-
Kui X., Sun M., Xie T., Wang W., Jiang L., Yan M., et al. The expression, purification, and immunogenicity of a new chimeric virus-like particle. Viral Immunol 2009, 22:49-56.
-
(2009)
Viral Immunol
, vol.22
, pp. 49-56
-
-
Kui, X.1
Sun, M.2
Xie, T.3
Wang, W.4
Jiang, L.5
Yan, M.6
-
42
-
-
0024318344
-
Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector
-
Urakawa T., Ferguson M., Minor P.D., Cooper J., Sullivan M., Almond J.W., et al. Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol 1989, 70(Pt 6):1453-1463.
-
(1989)
J Gen Virol
, vol.70
, Issue.PART 6
, pp. 1453-1463
-
-
Urakawa, T.1
Ferguson, M.2
Minor, P.D.3
Cooper, J.4
Sullivan, M.5
Almond, J.W.6
-
43
-
-
79952060998
-
Advances in human papilloma virus vaccines: a patent review
-
Cho H.-J., Oh Y.-K., Kim Y.B. Advances in human papilloma virus vaccines: a patent review. Expert Opin Ther Pat 2011, 21:295-309.
-
(2011)
Expert Opin Ther Pat
, vol.21
, pp. 295-309
-
-
Cho, H.-J.1
Oh, Y.-K.2
Kim, Y.B.3
-
44
-
-
0028309443
-
Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3
-
Zhang H., Yousef G.E., Ouyang X., Archard L.C. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3. Int J Exp Pathol 1994, 75:99-110.
-
(1994)
Int J Exp Pathol
, vol.75
, pp. 99-110
-
-
Zhang, H.1
Yousef, G.E.2
Ouyang, X.3
Archard, L.C.4
-
45
-
-
0028969648
-
A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin
-
Geller T.J., Condie D. A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin. J Neurol Sci 1995, 129:131-133.
-
(1995)
J Neurol Sci
, vol.129
, pp. 131-133
-
-
Geller, T.J.1
Condie, D.2
-
46
-
-
0024603936
-
Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia
-
Hertel N.T., Pedersen F.K., Heilmann C. Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia. Eur J Pediatr 1989, 148:642-643.
-
(1989)
Eur J Pediatr
, vol.148
, pp. 642-643
-
-
Hertel, N.T.1
Pedersen, F.K.2
Heilmann, C.3
-
47
-
-
0031688798
-
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
-
Kew O.M., Sutter R.W., Nottay B.K., McDonough M.J., Prevots D.R., Quick L., et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 1998, 36:2893-2899.
-
(1998)
J Clin Microbiol
, vol.36
, pp. 2893-2899
-
-
Kew, O.M.1
Sutter, R.W.2
Nottay, B.K.3
McDonough, M.J.4
Prevots, D.R.5
Quick, L.6
-
48
-
-
0033773155
-
Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice
-
Yu C.K., Chen C.C., Chen C.L., Wang J.R., Liu C.C., Yan J.J., et al. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 2000, 7:523-528.
-
(2000)
J Biomed Sci
, vol.7
, pp. 523-528
-
-
Yu, C.K.1
Chen, C.C.2
Chen, C.L.3
Wang, J.R.4
Liu, C.C.5
Yan, J.J.6
-
49
-
-
18144371146
-
+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio
-
+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio. J Virol 2005, 79:5988-5995.
-
(2005)
J Virol
, vol.79
, pp. 5988-5995
-
-
Wahid, R.1
Cannon, M.J.2
Chow, M.3
-
50
-
-
45749156795
-
Identification of human CD4 T-cell epitopes on the VP1 capsid protein of enterovirus 71
-
Foo D.G.W., Macary P.A., Alonso S., Poh C.L. Identification of human CD4 T-cell epitopes on the VP1 capsid protein of enterovirus 71. Viral Immunol 2008, 21:215-224.
-
(2008)
Viral Immunol
, vol.21
, pp. 215-224
-
-
Foo, D.G.W.1
Macary, P.A.2
Alonso, S.3
Poh, C.L.4
-
51
-
-
84856051431
-
Virus-like particles induce robust human T helper cell responses
-
Braun M., Jandus C., Maurer P., Hammann-Haenni A., Schwarz K., Bachmann M.F., et al. Virus-like particles induce robust human T helper cell responses. Eur J Immunol 2012, 42(2):330-340.
-
(2012)
Eur J Immunol
, vol.42
, Issue.2
, pp. 330-340
-
-
Braun, M.1
Jandus, C.2
Maurer, P.3
Hammann-Haenni, A.4
Schwarz, K.5
Bachmann, M.F.6
|